Qube Research & Technologies LTD Cullinan Oncology, Inc. Transaction History

Qube Research & Technologies LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$15.63 - $29.35 $1.18 Million - $2.21 Million	75,408 Added 65.51%	190,520 $3.32 Million
Q1 2024 May 14, 2024	BUY	$10.17 - $19.02 $1.1 Million - $2.06 Million	108,266 Added 1581.45%	115,112 $1.96 Million
Q4 2023 Feb 13, 2024	BUY	$7.89 - $10.23 $54,014 - $70,034	6,846 New	6,846 $69,000
Q2 2022 Aug 15, 2022	SELL	$7.31 - $13.55 $121,550 - $225,309	-16,628 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$10.47 - $16.75 $141,596 - $226,527	-13,524 Reduced 44.85%	16,628 $174,000
Q4 2021 Feb 01, 2022	BUY	$15.36 - $25.0 $463,134 - $753,800	30,152 New	30,152 $465,000

146

67.6M

612K

118K

Ticker CGEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,612,200
Market Cap $548M
Description
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.